Gadolinium complex of DO3A-benzothiazole aniline (BTA) conjugate as a theranostic agent

Journal of Medicinal Chemistry

Volumn 56, Issue 20, 2013, Pages 8104-8111

  Kim, Hee Kyung ^a   Kang, Min Kyoung ^a   Jung, Ki Hye ^a   Kang, Sun Hee ^a   Kim, Yeoun Hee ^b   Jung, Jae Chang ^a   Lee, Gang Ho ^a   Chang, Yongmin ^a   Kim, Tae Jeong ^a  

^a Kyungpook National University   (South Korea)

^b Cheil Eye Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TRISACETIC ACID; ACETIC ACID DERIVATIVE; ANILINE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOTHIAZOLE ANILINE; BENZOTHIAZOLE DERIVATIVE; GADOLINIUM; GADOTERATE MEGLUMINE; GADOTERIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; DRUG DESIGN; DRUG SYNTHESIS; FEMALE; KINETICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR CELL; TUMOR VOLUME;

ANIMALS; BENZOTHIAZOLES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CONTRAST MEDIA; FEMALE; GADOLINIUM; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR STRUCTURE; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; SENSITIVITY AND SPECIFICITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84886549869     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401206t     Document Type: Article

References (27)

1. Bradshaw, T. D.; Westwell, A. D. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate Curr. Med. Chem. 2004, 11, 1009-1021
2. Brantley, E.; Trapani, V.; Alley, M. C.; Hose, C. D.; Bradshaw, T. D.; Stevens, M. F.; Sausville, E. A.; Stinson, S. F. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells Drug. Metab. Dispos. 2004, 32, 1392-1401
3. 99mTc) Conjugated to 2-(4-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals J. Med. Chem. 2006, 49, 5408-5410
4. Tzanopoulou, S.; Sagnou, M.; Paravatou-Petsotas, M.; Gourni, E.; Loudos, G.; Xanthopoulos, S.; Lafkas, D.; Kiaris, H.; Varvarigou, A.; Pirmettis, I. C.; Papadopoulos, M.; Pelecanou, M. Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals J. Med. Chem. 2010, 53, 4633-4641
5. Chen, X.; Yu, P.; Zhang, L.; Liu, B. Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for beta-amyloid plaques in the brain Bioorg. Med. Chem. Lett. 2008, 18, 1442-1445
6. Mathis, C. A.; Wang, Y.; Holt, D. P.; Huang, G. F.; Debnath, M. L.; Klunk, W. E. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J. Med. Chem. 2003, 46, 2740-2754
7. Martins, A. F.; Morfin, J.-F.; Kubíčková, A.; Kubíček, V.; Buron, F.; Suzenet, F.; Salerno, M.; Lazar, A. N.; Duyckaerts, C.; Arlicot, N.; Guilloteau, D.; Geraldes, C. F. G. C.; Tóth, é. PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques J. Med. Chem. Lett. 2013, 4, 436-440
8. Saini, N.; Varshney, R.; Tiwari, A. K.; Kaul, A.; Allard, M.; Ishar, M. P.; Mishra, A. K. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent Dalton Trans. 2013, 42, 4994-5003
9. Katz, E.; Willner, I. Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications Angew. Chem., Int. Ed. Engl. 2004, 43, 6042-6108
10. Chen, K.; Li, Z. B.; Wang, H.; Cai, W.; Chen, X. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 2235-2244
11. Steiniger, S. C.; Kreuter, J.; Khalansky, A. S.; Skidan, I. N; Bobruskin, A. I.; Smimova, Z. S.; Severin, S. E.; Uhi, R.; Kock, M.; Geiger, K. D.; Gelperina, S. E. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles Int. J. Cancer 2004, 5, 759-767
12. Akine, Y.; Tokita, N.; Tokuuye, K.; Satoh, M.; Fukumori, Y.; Tokumitsu, H.; Kanamori, R.; Kobayashi, T.; Kanda, K. Neutron-Capture Therapy of Murine Ascites Tumor with Gadolinium-Containing Microcapsules J. Cancer Res. Clin. Oncol. 1992, 119, 71-73
13. De Jong, W. H.; Borm, P. J. Drug delivery and nanoparticles:applications and hazards Int. J. Nanomed. 2008, 3, 133-149
14. William, W. N., Jr.; Zinner, R. G.; Karp, D. D.; Oh, Y. W.; Glisson, B. S.; Phan, S. C.; Stewart, D. J. Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer J. Thorac. Oncol. 2007, 2, 745-750
15. Crossley, E. L.; Aitken, J. B.; Vogt, S.; Harris, H. H.; Rendina, L. M. Selective aggregation of a platinum-gadolinium complex within a tumor-cell nucleus Angew. Chem., Int. Ed. Engl. 2010, 49, 1231-3
16. Shih, J. L. A.; Brugger, R. M. Gadolinium as a Neutron-Capture Therapy Agent Med. Phys. 1992, 19, 733-744
17. Salt, C.; Lennox, A. J.; Takagaki, M.; Maguire, J. A.; Hosmane, N. S. Boron and gadolinium neutron capture therapy Russ. Chem. Bull. Int. Ed. 2004, 53, 1871-1888
18. Crossley, E. L.; Ziolkowski, E. J.; Coderre, J. A.; Rendina, L. M. Boronated DNA-binding compounds as potential agents for boron neutron capture therapy Mini-Rev. Med. Chem. 2007, 7, 303-313
19. Yamamoto, T.; Nakai, K.; Matsumura, A. Boron neutron capture therapy for glioblastoma Cancer Lett. 2008, 262, 143-152
20. Laurent, S.; Elst, L. V.; Copoix, F.; Muller, R. N. Stability of MRI paramagnetic contrast media-a proton relaxometric protocol for transmetallation assessment Invest. Radiol. 2001, 36, 115-122
21. Avedano, S.; Tei, L.; Lombardi, A.; Giovenzana, G. B.; Aime, S.; Longo, D.; Botta, M. Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange Chem. Commun. 2007, 4726-4728
22. Henrotte, V.; Vander Elst, L.; Laurent, S.; Muller, R. N. Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin J. Biol. Inorg. Chem. 2007, 12, 929-937
23. Yamane, T.; Hanaoka, K.; Muramatsu, Y.; Tamura, K.; Adachi, Y.; Miyashita, Y.; Hirata, Y.; Nagano, T. Method for enhancing cell penetration of Gd3+-based MRI contrast agents by conjugation with hydrophobic fluorescent dyes Bioconjugate Chem. 2011, 22, 2227-2236
24. Ian Hutchinson, S. A. J.; Vishnuvajjala, B. R.; Westwell, A. D.; Stevens, M. F. G.; Westwell, A. D. Antitumor Benzothiazoles. 16.1. Synthesis and Pharmaceutical Properties of Antitumor 2-(4-Aminophenyl)benzothiazole Amino Acid Prodrugs J. Med. Chem. 2002, 45, 744-747
25. Gu, S.-W.; Kim, H.-K.; Kang, B.-S.; Chang, Y.; Kim, T.-J. Gd-Complexes of 1,4,7,10-tetraazacyclododecane- N, N ', N ', N â€́-1,4,7,10- tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents J. Med. Chem. 2011, 54, 143-152
26. Lokling, K. E.; Fossheim, S. L.; Klaveness, J.; Skurtveit, R. Biodistribution of pH-responsive liposomes for MRI and a novel approach to improve the pH-responsiveness J. Controlled Release 2004, 98, 87-95
27. Kubota, T.; Kubouchi, K.; Koh, J.; Enomoto, K.; Ishibiki, K.; Abe, O. Human Breast Carcinoma (MCF-7) Serially Transplanted into Nude Mice Jpn. J. Surg. 1983, 13, 381-384